OakChart

Immunovant Inc

IMVTHealthcare·Biotechnology·USA·Mid·NASD·Nov 13 • 7:10 AM ET

34.80-0.25 (-0.71%)
2026-11-13 13:56 CET
Market cap
$7.20B
Revenue, TTM
0.00 USD m
Net income, TTM
-508.96 USD m
Free cash flow, TTM
-395.01 USD m
EPS diluted, TTM
-2.55
Price / earnings
-
Compare

Price

IMVT against its 20, 50 and 200-day averages
Terms2050200BeatMiss
Patternshover a marker to name it
RS 52Sales 0.00Price0.0030.0040.009.8M19.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IMVTclose 34.8020-day 30.5750-day 32.65200-day 32.3534.8052w high 45.4252w low 21.8652-week range, not 6 months

23.4% under the 52-week high of 45.42 on 19 Aug 2026. 52-week low 21.86 on 21 Nov 2025. Last 15 sessions, 36.1% high to low

Volume 0.02× normal · the line is the 50-bar volume average

Setup. RS line 52
CANSLIM 4 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High
VCP 4 of 6 — fails: 52-Week High/Low: 0-10% below High; RSI (14): Not Overbought (<60)
Minervini 3 of 4 — fails: 52-Week High/Low: 0-10% below High
Zanger 3 of 5 — fails: 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 4 of 5 — fails: 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15% — not on the tape: Net Profit Margin: High (>20%); P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 4 of 4
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

IMVT
52-week range, 55% of the way up
21.8645.42

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded on July 6, 2018 and is headquartered in Durham, NC.

IndexRUT
Employees315
IPOJun 21, 2019
Beta0.93
ATR, 14d1.54
Rel volume0.02
Short float21.83%
Insider own58.93%
Inst own52.40%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$7.20B
Enterprise Value6.48B
Income-508.96M
Sales0.00M
Book / share3.18
Cash / share3.49
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees315
IPOJun 21, 2019

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales-
Price / book10.95
Price / cash9.97
Price / free cash flow-
Value / cash profit-
Value / sales-
Quick Ratio7.31
Current Ratio7.31
Debt / equity0.00
Long-term debt / equity0.00
Options and shortYes / Yes

Earnings

Earnings / share-2.55
Earnings next year-2.50
Earnings next quarter-0.59
Earnings this year11.41%
Earnings next year-1.83%
Earnings growth, 5 years16.55%
Past earnings growth-17.37% -17.75%
Past sales growth- -
Earnings vs last year9.82%
Sales vs last year-
Earnings vs last quarter35.42%
Sales vs last quarter-
EarningsNov 09 BMO
Surprise36.23% -

Ownership

Insiders own58.93%
Insider trades-0.31%
Institutions own52.40%
Institution trades0.75%
Return on assets-75.74%
Return on equity-86.51%
Return on capital-77.47%
Gross Margin-
Operating margin-
Profit Margin-
20-day average13.84%
50-day average6.59%
200-day average7.57%

Technical

Shares out206.79M
Shares floating84.99M
Short / float21.83%
Short ratio12.91
Short interest18.55M
52-week high45.42 -23.4%
52-week low21.86 +59.2%
Volatility6.32% 4.59%
Average range1.54
Strength index60.50
Market sensitivity0.93
Relative volume0.02
Avg Volume1.44M
Volume1,115

Performance

Perf Week13.99%
Perf Month26.50%
Perf Quarter-20.38%
Perf Half Y26.59%
Perf YTD36.90%
Perf Year52.50%
Perf 3Y6.10%
Perf 5Y307.02%
Perf 10Y-
Recommendation1.47
Target Price48.62
Prev Close35.05
Price34.80
Change %-0.71%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Mar 20, 2026InitiatedBernsteinMkt Perform$28-19.5%
Jan 06, 2026UpgradeWolfe ResearchPeer Perform → Outperform$50+43.7%
Oct 14, 2025InitiatedTruistHold$16-54.0%
Jul 10, 2025ResumedGoldmanNeutral$18-48.3%
Mar 03, 2025InitiatedJefferiesHold$20-42.5%
Jan 03, 2025DowngradeWolfe ResearchOutperform → Peer Perform
Oct 10, 2024ResumedRaymond JamesOutperform$36+3.4%
Oct 09, 2024ReiteratedOppenheimerOutperform$47 → $53+52.3%
Mar 28, 2024InitiatedOppenheimerOutperform$50+43.7%
Mar 13, 2024InitiatedGoldmanBuy$50+43.7%

Peers

Mkt cap
TickerCompanyMkt cap
ARGXArgen X SE ADR61.91B
VRDNViridian Therapeutics Inc3.45B
DNTHDianthus Therapeutics Inc5.21B
ROIVRoivant Sciences Ltd28.99B
SYRESpyre Therapeutics Inc9.77B
VERAVera Therapeutics Inc2.06B
JNJJohnson & Johnson686.08B
KYTXKyverna Therapeutics Inc309.21M
CABACabaletta Bio Inc284.82M
AMGNAMGEN Inc254.23B

Insider trading

latest 14 of 69
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Pande AtulDirectorNov 11 '26Option Exercise8.433,00025,290119,731Nov 12 04:41 PM
Pande AtulDirectorNov 11 '26Sale36.003,000108,000116,731Nov 12 04:41 PM
Atul PandeDirectorNov 11 '26Proposed Sale35.716,000214,260Nov 12 07:58 AM
Girao TiagoChief Financial OfficerOct 28 '26Sale28.506,606188,271234,192Oct 30 04:37 PM
Stout Jay SChief Technology OfficerOct 21 '26Sale28.942,59575,099198,937Oct 23 04:55 PM
Stout Jay SChief Technology OfficerOct 07 '26Sale32.063,809122,117201,532Oct 09 05:05 PM
Van Tuyl ChristopherChief Legal OfficerOct 07 '26Sale32.061,32742,544175,218Oct 09 05:05 PM
Gloria MelanieChief Operating OfficerOct 07 '26Sale32.062,24171,846217,060Oct 09 05:04 PM
Venker EricChief Executive OfficerOct 01 '26Option Exercise14.4692,1871,333,024346,467Oct 05 07:42 PM
Venker EricChief Executive OfficerOct 02 '26Sale34.113,506119,590257,075Oct 05 07:42 PM
Van Tuyl ChristopherChief Legal OfficerSep 23 '26Sale36.362,846103,481176,545Sep 25 04:05 PM
Pande AtulDirectorAug 28 '26Option Exercise8.431,50012,645118,231Aug 28 04:27 PM
Pande AtulDirectorAug 28 '26Sale43.271,50064,905116,731Aug 28 04:27 PM
Gloria MelanieChief Operating OfficerAug 20 '26Sale44.163,056134,953219,301Aug 21 04:03 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
XBIState Street SPDR S&P Biotech ETFAUM: 10.59B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.68B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
IBBiShares Biotechnology ETFAUM: 11.39B
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B
SCHASchwab U.S. Small-Cap ETFAUM: 22.44B

News

latest 14 of 200

Quarterly earnings

2026Q2 EPS -0.470 beat -0.737, from -0.730 a year earlier. Sales 0.00 matched 0.00, from 0.00 a year earlier
EPS
0.0000-0.7602024Q3 EPS -0.760 against -0.75224Q32024Q4 EPS -0.640 against -0.71324Q42025Q1 EPS -0.710 against -0.68025Q12025Q2 EPS -0.730 against -0.71425Q22025Q3 EPS -0.610 against -0.71325Q32025Q4 EPS -0.730 against -0.59225Q42026Q1 EPS -0.750 against -0.62926Q12026Q2 EPS -0.470 against -0.73726Q2
Sales, USD millions
0.890-0.892024Q3 sales 0.00 against 0.0024Q32024Q4 sales 0.00 against 0.0024Q42025Q1 sales 0.00 against 0.0025Q12025Q2 sales 0.00 against 0.0025Q22025Q3 sales 0.00 against 0.0025Q32025Q4 sales 0.00 against 0.0025Q42026Q1 sales 0.00 against 0.0026Q12026Q2 sales 0.00 against 0.0026Q2

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q2ended 2026-09-302026-11-09 08:30-0.470-0.737-0.4700.000.00EPS -36.2% · sales -vs 2025Q2, year-ago quarter · EPS -35.6% · sales -14 EPS · 7 salesOpen +9.14% vs SPY +0.91%. Close +15.13% vs SPY +2.37%
2026Q1ended 2026-06-302026-08-06 08:30-0.750-0.629-0.7450.000.00EPS +19.3% · sales -vs 2025Q1, year-ago quarter · EPS +5.6% · sales -12 EPS · 6 salesOpen -3.31% vs SPY +0.05%. Close +1.17% vs SPY -0.16%
2025Q4ended 2026-03-312026-05-20 08:30-0.730-0.592-0.7260.000.00EPS +23.3% · sales -vs 2024Q4, year-ago quarter · EPS +14.1% · sales -16 EPS · 10 salesOpen +15.79% vs SPY +0.27%. Close +35.26% vs SPY +1.02%
2025Q3ended 2025-12-312026-02-06 08:30-0.610-0.713-0.6100.000.00EPS -14.5% · sales -vs 2024Q3, year-ago quarter · EPS -19.7% · sales -14 EPS · 8 salesOpen +11.72% vs SPY +0.57%. Close +12.43% vs SPY +1.92%
2025Q2ended 2025-09-302025-11-10 08:30-0.730-0.714-0.7290.000.00EPS +2.2% · sales -vs 2024Q2, year-ago quarter · EPS -1.4% · sales -15 EPS · 8 salesOpen -2.53% vs SPY +0.93%. Close +0.09% vs SPY +1.56%
2025Q1ended 2025-06-302025-08-11 08:30-0.710-0.680-0.7060.000.00EPS +4.4% · sales -vs 2024Q1, year-ago quarter · EPS +34.8% · sales -12 EPS · 5 salesOpen +0.26% vs SPY +0.04%. Close -4.53% vs SPY -0.20%
2024Q4ended 2025-03-312025-05-29 08:30-0.640-0.713-0.6380.000.00EPS -10.3% · sales -vs 2023Q4, year-ago quarter · EPS +23.1% · sales -12 EPS · 8 salesOpen +4.61% vs SPY +0.91%. Close +5.60% vs SPY +0.39%
2024Q3ended 2024-12-312025-02-06 08:30-0.760-0.752-0.7560.000.00EPS +1.1% · sales -vs 2023Q3, year-ago quarter · EPS +162.6% · sales -12 EPS · 8 salesOpen +2.18% vs SPY +0.29%. Close -9.55% vs SPY +0.35%
2024Q2ended 2024-09-302024-11-07 08:30-0.740-0.600-0.7450.000.00EPS +23.3% · sales -vs 2023Q2, year-ago quarter · EPS +64.4% · sales -15 EPS · 10 salesOpen -0.51% vs SPY +0.35%. Close -4.74% vs SPY +0.77%
2024Q1ended 2024-06-302024-08-06 16:30-0.527-0.524-0.5970.000.00EPS +0.5% · sales -vs 2023Q1, year-ago quarter · EPS -7.6% · sales -10 EPS · 6 salesOpen +0.32% vs SPY +1.21%. Close -3.12% vs SPY -0.67%
2023Q4ended 2024-03-312024-05-29 16:30-0.520-0.430-0.5180.000.00EPS +21.0% · sales -vs 2022Q4, year-ago quarter · EPS +13.0% · sales -14 EPS · 9 salesOpen -6.32% vs SPY -0.30%. Close -10.69% vs SPY -0.66%
2023Q3ended 2023-12-312024-02-12 08:30-0.289-0.433-0.3560.000.00EPS -33.1% · sales -vs 2022Q3, year-ago quarter · EPS -40.9% · sales -14 EPS · 8 salesOpen -4.37% vs SPY -0.01%. Close +3.35% vs SPY -0.04%
2023Q2ended 2023-09-302023-11-09 08:30-0.450-0.453-0.4470.000.00EPS -0.7% · sales -vs 2022Q2, year-ago quarter · EPS +9.8% · sales -14 EPS · 7 sales-
2023Q1ended 2023-06-302023-08-10 08:30-0.570-0.436-0.5670.000.00EPS +30.9% · sales -vs 2022Q1, year-ago quarter · EPS +62.9% · sales -12 EPS · 6 sales-
2022Q4ended 2023-03-312023-05-22 08:30-0.460-0.423-0.4590.000.00EPS +8.8% · sales -vs 2021Q4, year-ago quarter · EPS +12.2% · sales -13 EPS · 8 sales-
2022Q3ended 2022-12-312023-02-03 08:30-0.490-0.373-0.4920.000.00EPS +31.3% · sales -vs 2021Q3, year-ago quarter · EPS +36.1% · sales -9 EPS · 6 sales-

Annual earnings

2025FY EPS -2.770 missed -2.612, from -2.730 a year earlier. Sales 0.00 matched 0.00, from 0.00 a year earlier
EPS
0.0000-2.8072019FY EPS -1.540 against -1.09420192020FY EPS -1.220 against -1.30220202021FY EPS -1.430 against -1.41020212022FY EPS -1.710 against -1.60320222023FY EPS -1.880 against -1.78920232024FY EPS -2.730 against -2.80720242025FY EPS -2.770 against -2.6122025
Sales, USD millions
0.890-0.892019FY sales 0.00 against 0.0020192020FY sales 0.00 against 0.0020202021FY sales 0.00 against 0.0020212022FY sales 0.00 against 0.0020222023FY sales 0.00 against 0.0020232024FY sales 0.00 against 0.0020242025FY sales 0.00 against 0.002025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-2.807--1,68112.40
2029FYestimate-0.356--920.5597.84
2028FYestimate--1.610--393.03-
2027FYestimate--2.499--46.85-
2026FYestimate--2.454--0.00-
2025FY-2.770-2.612-2.7700.000.00-
2024FY-2.730-2.807-2.7300.000.00-
2023FY-1.880-1.789-1.8780.000.00-
2022FY-1.710-1.603-1.7140.000.00-
2021FY-1.430-1.410-1.4290.000.00-
2020FY-1.220-1.302-1.2240.000.00-
2019FY-1.540-1.094-1.5370.000.00-

Quarterly results

2026Q2 revenue 0.00, from 0.00 a year earlier
Revenue, USD millions
0.890-0.892024Q3 revenue 0.0024Q32024Q4 revenue 0.0024Q42025Q1 revenue 0.0025Q12025Q2 revenue 0.0025Q22025Q3 revenue 0.0025Q32025Q4 revenue 0.0025Q42026Q1 revenue 0.0026Q12026Q2 revenue 0.0026Q2

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E -2.45 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-10-2.45-2.3%
2026Q3Eper share2026-11-10-0.59-3.3%
2026FYRper share2026-11-10-2.49-5.8%
2026Q3Rper share2026-11-10-0.60-5.5%
2026Q3Sper share2026-11-090.00-
2026FYSper share2026-11-080.00-
2026Q2Eper share2026-11-04-0.740.0%
2026Q2Rper share2026-11-04-0.740.0%
2026Q2Sper share2026-08-210.00-
2026Q1Eper share2026-08-04-0.630.0%
2026Q1Rper share2026-08-04-0.650.0%
2026Q1Sper share2026-07-310.00-
2025FYEper share2026-04-25-2.610.0%
2025Q4Eper share2026-04-25-0.590.0%
2025FYRper share2026-04-22-2.600.0%
2025Q4Rper share2026-04-22-0.590.0%
2025FYSper share2026-03-180.00-
2025Q4Sper share2026-02-130.00-
2025Q3Eper share2026-02-01-0.710.0%
2025Q3Rper share2026-02-01-0.690.0%
2025Q2Sper share2025-11-100.00-
2025Q3Sper share2025-11-100.00-
2025Q2Eper share2025-11-01-0.71+0.6%
2025Q2Rper share2025-11-01-0.70+1.0%
2025Q1Sper share2025-07-310.00-
2025Q1Eper share2025-07-25-0.68-1.5%
2025Q1Rper share2025-07-25-0.68-1.2%
2024FYEper share2025-05-29-2.810.0%
2024Q4Eper share2025-05-29-0.710.0%
2024FYRper share2025-05-29-2.730.0%
2024Q4Rper share2025-05-29-0.680.0%
2024FYSper share2025-05-290.00-
2024Q4Sper share2025-05-290.00-
2024Q3Eper share2025-01-31-0.75+0.1%
2024Q3Rper share2025-01-21-0.730.0%
2024Q3Sper share2024-12-100.00-
2024Q2Eper share2024-10-23-0.590.0%
2024Q2Rper share2024-10-21-0.610.0%
2024Q2Sper share2024-09-060.00-
2024Q1Eper share2024-06-12-0.53-1.3%
2024Q1Rper share2024-06-12-0.55-1.6%
2024Q1Sper share2024-05-300.00-
2023FYEper share2024-05-28-1.79-0.1%
2023Q4Eper share2024-05-28-0.43-0.3%
2023FYRper share2024-05-28-1.78-0.3%
2023Q4Rper share2024-05-28-0.45-0.1%
2023FYSper share2024-05-280.00-
2023Q4Sper share2024-04-120.00-

Estimate history

Annual
Metric20182019202020212022202320242025TTMMRQ
EPS per share0.00-1.537-1.224-1.429-1.714-1.878-2.73-2.772-2.5513-
Sales USD millions000000000-
Shares million shares145598116130146170204-207
Quarterly
MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
EPS per share-0.745-0.756-0.638-0.706-0.729-0.61-0.726-0.745-0.471
Sales USD millions000000000
Shares million shares147147170171175203204206207

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY3/31/20262024FY3/31/20252023FY3/31/20242022FY3/31/20232021FY3/31/20222020FY3/31/20212019FY3/31/20202018FY12/31/2018
Total Revenue0.000.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.380.41+7.9%0.38+65.2%0.23-82.6%1.32+7.3%1.23+23.0%1.00+4900.0%0.020.00
Gross Profit-0.38-0.41-0.38-0.23-1.32-1.23-1.00-0.020.00
Selling, General and Administrative Excl. Other538.02532.49+21.6%437.77+62.1%269.98+30.5%206.95+33.7%154.80+44.5%107.12+79.6%59.660.00
Research and Development468.85456.66+26.5%360.92+69.5%212.93+32.9%160.26+57.4%101.81+48.4%68.60+43.1%47.93-
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-538.39-532.90-438.15-270.21-208.28-156.03-108.12-59.68-0.00
Interest Expense0.000.000.000.00--0.00-100.0%0.62-
Unusual Expense0.000.000.00-100.0%12.50+25.0%10.000.000.00-100.0%6.40-
Net Income Before Taxes-510.25-505.39-412.95-258.77-210.95-156.81-107.79-66.29-0.00
Income Taxes-1.290.21-76.4%0.89+56.1%0.57+5600.0%0.01-0.08-0.36-460.0%0.100.00
Consolidated Net Income-508.96-505.61-413.84-259.34-210.96-156.73-107.43-66.39-0.00
Net Income From Continuing Operations-508.96-505.61-413.84-259.34-210.96-156.73-107.43-66.39-0.00
Net Income-508.96-505.61-413.84-259.34-210.96-156.73-107.43-66.39-0.00
EPS (Recurring) per share-2.46-2.77-2.73-1.81-1.66-1.43-1.22-1.43-0.00
EPS (Basic, Before Extraordinaries) per share-2.55-2.77-2.73-1.88-1.71-1.43-1.22-1.540.00
EPS (Diluted) per share-2.55-2.77-2.73-1.88-1.71-1.43-1.22-1.540.00
EBITDA-538.02-532.49-437.77-269.98-206.95-154.80-107.12-59.66-0.00
Non-Operating Income (Expense)28.1427.51+9.2%25.20+5.3%23.94+226.6%7.33-0.78-336.4%0.33-19.5%0.410.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense42.2943.36+11.0%39.08+20.6%32.40+28.3%25.25-3.6%26.18+92.4%13.61+174.4%4.96-
Shares Outstanding million shares206.79203.94+19.9%170.11+16.8%145.58+11.7%130.33+11.9%116.48+18.9%97.97+79.2%54.66+280.1%14.38
Market Capitalization7,253.537,253.53+149.9%2,902.92-38.2%4,694.42+132.4%2,020.10+215.0%641.34-59.2%1,571.46+602.3%223.75-6.0%237.91

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q29/30/20262026Q16/30/20262025Q43/31/20262025Q312/31/20252025Q29/30/20252025Q16/30/20252024Q43/31/20252024Q312/31/2024
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.09-10.0%0.09-18.2%0.10-9.1%0.100.0%0.10+11.1%0.11+37.5%0.11+83.3%0.10+66.7%
Gross Profit-0.09-0.09-0.10-0.10-0.10-0.11-0.11-0.10
Selling, General and Administrative Excl. Other104.07-21.0%160.23+26.0%159.46+40.2%114.26+0.1%131.66+13.8%127.12+34.9%113.72+40.7%114.20+85.7%
Research and Development85.01-25.6%142.63+40.9%142.29+51.9%98.92+4.7%114.25+17.5%101.20+34.1%93.65+41.8%94.52+95.5%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-104.16-160.32-159.55-114.36-131.76-127.22-113.83-114.30
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-97.25-153.22-150.70-109.08-125.91-119.70-105.87-110.97
Income Taxes0.00-100.0%0.00-100.0%-2.84-589.7%1.55+933.3%0.59+637.5%0.91+1037.5%0.58+152.2%0.15
Consolidated Net Income-97.25-153.22-147.86-110.64-126.50-120.61-106.45-111.12
Net Income From Continuing Operations-97.25-153.22-147.86-110.64-126.50-120.61-106.45-111.12
Net Income-97.25-153.22-147.86-110.64-126.50-120.61-106.45-111.12
EPS (Recurring) per share-0.47-0.75-0.73-0.61-0.73-0.71-0.64-0.76
EPS (Basic, Before Extraordinaries) per share-0.47-0.75-0.73-0.61-0.73-0.71-0.64-0.76
EPS (Diluted) per share-0.47-0.75-0.73-0.61-0.73-0.71-0.64-0.76
EBITDA-104.07-160.23-159.46-114.26-131.66-127.12-113.72-114.20
Non-Operating Income (Expense)6.91+18.1%7.10-5.6%8.85+11.2%5.28+58.6%5.85-12.7%7.52+4.3%7.96+37.5%3.33-66.8%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.89+23.7%10.69-26.4%8.80-4.7%9.90+7.6%10.42+4.0%14.53+36.8%9.23+21.0%9.20+14.1%
Shares Outstanding million shares206.79+18.5%206.26+20.6%203.94+19.9%203.32+38.1%174.53+19.1%171.07+17.0%170.11+16.8%147.20+1.5%
Market Capitalization7,253.53+158.1%7,910.56+189.3%5,055.73+74.2%5,121.55+40.9%2,809.99-32.7%2,734.77-29.1%2,902.92-38.2%3,635.86-40.3%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY3/31/20262024FY3/31/20252023FY3/31/20242022FY3/31/20232021FY3/31/20222020FY3/31/20212019FY3/31/20202018FY12/31/2018
Cash & Short Term Investments902.11+26.4%713.97+12.4%635.37+68.7%376.53-23.8%493.82+23.4%400.15+297.9%100.57+30375.8%0.33
Short Term Receivables3.95+57.4%2.51-54.4%5.50+518.0%0.89-93.1%12.86+2238.2%0.55-81.9%3.040.00
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets42.76-16.5%51.18+105.5%24.90-7.5%26.92+330.7%6.25-24.8%8.31+52.2%5.460.00
Total Current Assets948.82+23.6%767.66+15.3%665.77+64.7%404.33-21.2%512.93+25.4%409.01+275.0%109.08+32954.5%0.33
Net Property, Plant & Equipment0.52-44.7%0.94+59.3%0.59-60.7%1.50-43.0%2.63-24.4%3.48+4871.4%0.070.00
Total Investments and Advances0.000.000.000.000.000.000.000.00
Intangible Assets--0.000.000.000.000.000.00
Deferred Tax Assets0.55-50.0%1.10+214.3%0.35-----
Other Assets7.68+0.8%7.620.000.000.000.00-100.0%0.25+212.5%0.08
Total Assets957.57+23.2%777.32+16.6%666.71+64.3%405.84-21.3%515.56+25.0%412.49+277.1%109.39+26580.5%0.41
Short Term Debt Incl. Current Port. of LT Debt0.07-30.0%0.10-28.6%0.14-90.8%1.52+15.2%1.32+11.9%1.18-63.0%3.19+963.3%0.30
Accounts Payable7.54-57.3%17.66+146.6%7.16+430.4%1.35-92.8%18.63+666.7%2.43+104.2%1.190.00
Other Current Liabilities96.81+89.7%51.02+23.5%41.31+2.2%40.42+64.5%24.57+62.1%15.16+38.6%10.94+13575.0%0.08
Total Current Liabilities104.42+51.8%68.78+41.5%48.61+12.3%43.30-2.7%44.52+137.2%18.77+22.5%15.32+3931.6%0.38
Long Term Debt0.000.000.00-100.0%0.05-95.9%1.22-45.5%2.240.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.55-50.0%1.10+214.3%0.35-----
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities104.97+50.2%69.87+42.7%48.95+12.9%43.34-5.2%45.74+117.7%21.01+37.1%15.32+3931.6%0.38
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity852.59+20.5%707.45+14.5%617.76+70.4%362.49-22.8%469.82+20.0%391.48+316.2%94.07+470250.0%0.02
Total Shareholders Equity852.59+20.5%707.45+14.5%617.76+70.4%362.49-22.8%469.82+20.0%391.48+316.2%94.07+470250.0%0.02
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity852.59+20.5%707.45+14.5%617.76+70.4%362.49-22.8%469.82+20.0%391.48+316.2%94.07+470250.0%0.02
Total Liabilities & Stockholders Equity957.57+23.2%777.32+16.6%666.71+64.3%405.84-21.3%515.56+25.0%412.49+277.1%109.39+26580.5%0.41
Book Value Per Share per share4.18+0.5%4.16-1.9%4.24+52.5%2.78-31.0%4.03+0.8%4.00+132.6%1.720.00
Tangible Book Value Per Share per share4.18+0.5%4.16-1.9%4.24+52.5%2.78-31.0%4.03+0.8%4.00+132.6%1.720.00
Full-Time Employees people315-13.0%362+74.9%207+26.2%164+32.3%124+82.4%680-
Price to Book Ratio ratio11.037.136.905.581.374.019.048.09
Return on Assets %-58.29-57.32-48.36-45.79-33.78-41.17-120.93-
Return on Equity %-64.82-62.46-52.91-50.69-36.39-44.25-141.11-
Return on Invested Capital %-59.30-58.50-41.98-58.19-33.27-27.29-70.57-1.82
Quick Ratio ratio9.0911.1613.709.3411.5221.797.120.85
Current Ratio ratio9.0911.1613.709.3411.5221.797.120.85

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY3/31/20262024FY3/31/20252023FY3/31/20242022FY3/31/20232021FY3/31/20222020FY3/31/20212019FY3/31/20202018FY12/31/2018
Net Income-508.96-505.61-413.84-259.34-210.96-156.73-107.43-66.39-0.00
Depreciation0.380.41+7.9%0.38+65.2%0.23-82.6%1.32+7.3%1.23+23.0%1.00+4900.0%0.02-
Other Funds (Non Cash)51.0255.82+12.5%49.62+17.4%42.25+30.8%32.30-5.7%34.24+84.7%18.54+126.1%8.200.00
Funds from Operations-457.57-449.37-363.84-216.86-177.34-121.25-87.89-58.16-0.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital62.5642.06-12.03-557.4%2.63-10.85-171.7%15.14+231.3%4.57-5.0%4.810.00
Cash from Operating Activities-395.00-407.31-375.87-214.23-188.19-106.11-83.33-53.360.00
Capital Expenditures-0.01-0.01-0.76-0.36-0.20-0.25-0.21-0.030.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.01-0.01-0.76-0.36-0.20-0.25-0.21-0.030.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock596.22595.76+31.1%454.49-3.8%472.43+566.4%70.89+54430.8%0.13-100.0%386.30-1.95-6600.0%0.03
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock596.22595.76+31.1%454.49-3.8%472.43+566.4%70.89+54430.8%0.13-100.0%386.30-1.95-6600.0%0.03
Proceedsfrom Stock Options543.69543.69+20.9%449.68-3.7%466.73+564.6%70.23+53923.1%0.13-100.0%385.39-1.95-6600.0%0.03
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00-3.19-108.4%37.91+12536.7%0.30
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.00-100.0%200.000.00-100.0%111.020.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities596.22595.76+31.1%454.49-3.8%472.43+566.4%70.89-64.6%200.13-47.8%383.11+160.7%146.97+44436.4%0.33
Exchange Rate Effect-0.81-0.30-140.0%0.75-24.2%0.99+350.0%0.22-0.09---
Net Change in Cash200.40188.14+139.3%78.61-69.6%258.83-117.28-225.2%93.67-68.7%299.57+220.1%93.59+28260.6%0.33
Free Cash Flow-395.01-407.32-376.63-214.59-188.39-106.37-83.54-53.390.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q29/30/20262026Q16/30/20262025Q43/31/20262025Q312/31/20252025Q29/30/20252025Q16/30/20252024Q43/31/20252024Q312/31/2024
Cash & Short Term Investments722.27+38.4%797.80+33.2%902.11+26.4%994.52+165.4%521.87+10.3%598.91+6.9%713.97+12.4%374.69-45.8%
Short Term Receivables0.14-92.9%0.70-63.9%3.95+57.4%1.64-26.1%1.97+4.8%1.94-19.8%2.51-54.4%2.22+115.5%
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets37.63-24.3%52.68+3.5%42.76-16.5%46.77+31.3%49.71+52.7%50.91+91.2%51.18+105.5%35.63+89.4%
Total Current Assets760.05+32.5%851.18+30.6%948.82+23.6%1,042.94+152.8%573.55+13.0%651.76+10.6%767.66+15.3%412.54-42.0%
Net Property, Plant & Equipment0.26-58.7%0.35-52.7%0.52-44.7%0.53-31.2%0.63-12.5%0.74+17.5%0.94+59.3%0.77+14.9%
Total Investments and Advances0.000.000.000.000.000.000.000.00
Deferred Tax Assets--0.55-50.0%---1.10+214.3%-
Other Assets0.66-92.5%0.96-89.3%7.68+0.8%8.92+17.1%8.78+15.2%8.947.627.62
Total Assets760.97+30.5%852.49+28.9%957.57+23.2%1,052.39+150.0%582.96+13.0%661.44+12.2%777.32+16.6%420.93-40.8%
Short Term Debt Incl. Current Port. of LT Debt0.000.000.07-30.0%0.00-100.0%0.00-100.0%0.00-100.0%0.10-28.6%0.02-93.5%
Accounts Payable6.79-1.9%10.14+29.3%7.54-57.3%8.62-56.5%6.92-66.6%7.84-29.0%17.66+146.6%19.82+406.9%
Other Current Liabilities97.23+72.6%106.96+137.4%96.81+89.7%57.64+18.9%56.34+22.8%45.06+32.9%51.02+23.5%48.48+73.8%
Total Current Liabilities104.02+64.5%117.10+121.4%104.42+51.8%66.26-3.0%63.25-5.1%52.90+17.5%68.78+41.5%68.31+112.8%
Long Term Debt0.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities--0.55-50.0%---1.10+214.3%-
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities104.02+64.5%117.10+121.4%104.97+50.2%66.26-3.0%63.25-5.1%52.90+17.5%69.87+42.7%68.31+112.8%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity656.95+26.4%735.39+20.8%852.59+20.5%986.13+179.7%519.71+15.7%608.54+11.7%707.45+14.5%352.62-48.1%
Total Shareholders Equity656.95+26.4%735.39+20.8%852.59+20.5%986.13+179.7%519.71+15.7%608.54+11.7%707.45+14.5%352.62-48.1%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity656.95+26.4%735.39+20.8%852.59+20.5%986.13+179.7%519.71+15.7%608.54+11.7%707.45+14.5%352.62-48.1%
Total Liabilities & Stockholders Equity760.97+30.5%852.49+28.9%957.57+23.2%1,052.39+150.0%582.96+13.0%661.44+12.2%777.32+16.6%420.93-40.8%
Book Value Per Share per share3.18+6.7%3.57+0.3%4.18+0.5%4.85+102.1%2.98-2.6%3.56-4.6%4.16-1.9%2.40-48.7%
Tangible Book Value Per Share per share3.18+6.7%3.57+0.3%4.18+0.5%4.85+102.1%2.98-2.6%3.56-4.6%4.16-1.9%2.40-48.7%
Full-Time Employees people--315-13.0%---362+74.9%-
Price to Book Ratio ratio11.039.225.128.544.533.857.138.08
Return on Assets %-75.74-71.10-58.29-63.01-84.59-71.50-57.32-67.59
Return on Equity %-86.51-80.10-64.82-69.35-95.93-77.58-62.46-74.17
Return on Invested Capital %-14.80-20.84-17.34-11.22-24.34-19.82-15.05-31.51
Quick Ratio ratio7.317.279.0915.749.0712.3211.166.04
Current Ratio ratio7.317.279.0915.749.0712.3211.166.04

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q29/30/20262026Q16/30/20262025Q43/31/20262025Q312/31/20252025Q29/30/20252025Q16/30/20252024Q43/31/20252024Q312/31/2024
Net Income-97.25-153.22-147.86-110.64-126.50-120.61-106.45-111.12
Depreciation0.09-10.0%0.09-18.2%0.10-9.1%0.100.0%0.10+11.1%0.11+37.5%0.11+83.3%0.10
Other Funds (Non Cash)13.31-0.5%13.80-25.5%11.17-4.6%12.74+9.1%13.38+5.3%18.53+37.1%11.71+17.9%11.68+5.2%
Funds from Operations-83.85-139.33-136.59-97.79-113.02-101.97-94.63-99.35
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.63-94.0%14.9341.535.4710.50+36.9%-15.44-16.01-384.9%-1.04
Cash from Operating Activities-83.22-124.41-95.06-92.33-102.52-117.41-110.64-100.39
Capital Expenditures0.000.00-0.010.000.000.00-0.20-0.18
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.00-0.010.000.000.00-0.20-0.18
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock7.88-68.0%20.10+588.4%3.64-99.2%564.60+22851.2%24.59+3268.5%2.92+323.2%450.61-5.0%2.46
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock7.88-68.0%20.10+588.4%3.64-99.2%564.60+22851.2%24.59+3268.5%2.92+323.2%450.61-5.0%2.46
Proceedsfrom Stock Options0.000.00544.28+21.0%-0.590.000.00449.68-4.9%0.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00-100.0%
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities7.88-68.0%20.10+588.4%3.64-99.2%564.60+22851.2%24.59+3268.5%2.92+323.2%450.61+29160.4%2.46-99.5%
Exchange Rate Effect-0.19-121.6%-0.00-0.990.380.88-16.2%-0.57-267.6%-0.49-117.9%-0.15
Net Change in Cash-75.52-104.31-92.42-127.2%472.65-77.04-115.06339.29-98.26-123.3%
Free Cash Flow-83.22-124.41-95.07-92.33-102.52-117.41-110.84-100.57

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3021.87%18.6M84.8M1.35M
2026-10-1521.54%18.3M84.8M1.29M
2026-09-3020.53%17.4M84.8M1.22M
2026-09-1520.34%17.3M84.8M1.26M
2026-08-3118.69%15.8M84.5M1.29M
2026-08-1420.11%17.0M84.5M1.70M
2026-07-3119.39%16.4M84.5M1.72M
2026-07-1521.71%17.8M81.8M1.89M
2026-06-3022.11%18.0M81.4M1.95M
2026-06-1523.79%19.3M81.3M1.84M
2026-05-2923.72%19.2M81.0M1.79M
2026-05-1525.16%20.4M81.0M1.36M
2026-04-3022.38%18.6M83.1M1.43M
2026-04-1523.49%19.5M83.0M1.34M
2026-03-3121.93%18.4M84.0M1.40M
2026-03-1319.71%16.6M84.0M1.46M
2026-02-2720.03%16.8M84.0M1.59M
2026-02-1320.17%17.0M84.0M1.63M
2026-01-3019.71%16.5M83.7M1.65M
2026-01-1520.24%16.9M83.7M1.80M

Option chain

Expiry 2026-11-20 · underlying 34.80, quoted 13 Nov 07:10 ET · ATM 35.00

Option quotes 12 Nov 12:45 ET. A date on a row is older than the last session (12 Nov). 56 rows.

Implied move 8.76% into expiry (call 1.925 + put 1.125 = 3.050 on 34.80)

Put/call open interest 0.49 (341 puts / 691 calls) · Put/call volume 0.10 (1 puts / 10 calls)

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
call 1 Jan19.00ITM14.4018.200.000.00509.1% +285.30000.979-0.0390.003
put 1 JanOTM0.002.150.000.00223.8% 0.0000-0.021-0.0370.003
call 1 Jan20.00ITM13.3017.200.000.00477.3% +270.10000.977-0.0390.003
put 30 OctOTM0.001.550.250.00207.2% 0.02600-0.023-0.0360.003
call 1 Jan21.00ITM12.3016.200.000.00447.2% +255.80000.976-0.0380.003
put 30 OctOTM0.001.750.300.00191.4% 0.01500-0.024-0.0360.003
call 1 Jan22.00ITM11.3015.200.000.00427.0% +250.70000.974-0.0380.003
put 22 OctOTM0.002.150.600.00176.2% 0.0900-0.026-0.0350.003
call 1 Jan23.00ITM10.3014.200.000.00391.0% +229.30000.971-0.0370.003
put 6 NovOTM0.002.150.350.00161.7% 0.0300-0.029-0.0350.003
call 1 Jan24.00ITM9.3013.200.000.00364.6% +216.90000.969-0.0370.004
put 5 NovOTM0.001.550.400.00147.7% 0.02900-0.031-0.0340.004
call 1 Jan25.00ITM8.3012.200.000.00339.1% +205.00000.966-0.0360.004
put 22 OctOTM0.002.151.200.00134.2% 0.04900-0.034-0.0330.004
call 19 Oct26.00ITM7.1011.203.700.00314.4% +193.45000.962-0.0350.004
put 26 OctOTM0.001.801.600.00121.0% 0.0200-0.038-0.0320.004
call 1 Jan27.00ITM6.4010.200.000.00290.5% +182.30000.958-0.0340.005
put 3 NovOTM0.001.901.110.00108.2% 0.0700-0.042-0.0310.005
call 11 Nov28.00ITM6.509.209.050.00267.1% +171.358000.953-0.0340.005
put 6 NovOTM0.000.801.020.0095.7% 0.02900-0.047-0.0300.005
call 5 Nov29.00ITM5.608.201.850.00244.1% +160.630000.947-0.0320.006
putOTM0.000.100.10-1.4083.5% 0.02111-0.053-0.0290.006
call 5 Nov30.00ITM4.607.301.500.00227.4% +28.7144000.753-0.2080.016
put 9 NovOTM0.001.750.410.00198.7% 0.01200-0.247-0.2050.016
call 10 Nov31.00ITM2.756.304.950.00204.7% +27.465000.728-0.1950.017
put 10 NovOTM0.002.100.400.00138.0% 0.05000-0.238-0.1390.016
call 9 Nov32.00ITM1.855.403.960.00187.4% +29.613000.696-0.1830.018
put 10 NovOTM0.002.300.550.00118.7% -4.23300-0.274-0.1330.017
call 6 Nov33.00ITM1.204.600.700.00174.7% +32.323000.654-0.1740.019
put 10 NovOTM0.002.400.950.00134.1% -8.3000-0.346-0.1700.019
call 22 Oct34.00ITM1.403.800.950.00160.6% +32.029000.603-0.1650.020
put 11 NovOTM0.001.750.380.0078.4% -28.4900-0.390-0.1330.020
call35.00ATM0.553.301.45-1.29159.7% +36.915510100.541-0.1620.020
put 11 NovATM0.501.750.680.0087.5% -35.23000-0.459-0.1580.020
call 11 Nov36.00OTM0.001.452.000.0090.4% +7.67000.439-0.1080.020
put 1 JanITM0.601.950.000.0069.6% -13.1000-0.561-0.1040.020
call 9 Nov37.00OTM0.002.000.900.00108.5% -6.04000.408-0.1470.020
put 21 SepITM0.254.404.800.00159.8% +39.61200-0.585-0.1510.020
call 9 Nov38.00OTM0.002.300.200.00124.8% -3.122000.370-0.1600.019
put 13 OctITM1.055.109.150.00162.0% +34.1400-0.630-0.1550.019
call 8 Oct39.00OTM0.002.200.950.00139.6% 0.066000.339-0.1690.019
put 1 JanITM1.906.000.000.00172.5% +32.9000-0.661-0.1640.019
call 11 Nov40.00OTM0.000.650.450.00106.4% 0.064000.222-0.1050.015
put 13 OctITM2.906.9010.950.00181.8% +75.4100-0.778-0.1000.015
call 1 Jan41.00OTM0.002.100.000.00117.7% 0.00000.207-0.1110.015
put 1 JanITM3.807.900.000.00195.2% +77.5000-0.793-0.1060.015
call 1 Jan42.00OTM0.002.150.000.00128.4% 0.00000.194-0.1160.014
put 1 JanITM4.808.900.000.00174.6% +46.2000-0.806-0.1120.014
call 1 Jan43.00OTM0.001.650.000.00138.5% 0.00000.184-0.1210.014
put 1 JanITM5.809.900.000.00219.9% +81.4000-0.816-0.1160.014
call 1 Jan44.00OTM0.001.700.000.00148.1% 0.00000.175-0.1260.013
put 1 JanITM6.8010.700.000.00208.7% +60.6000-0.825-0.1210.013
call 24 Sep45.00OTM0.002.151.450.00157.3% 0.02000.167-0.1300.013
put 1 JanITM7.8011.700.000.00219.2% +61.9000-0.833-0.1250.013
call 24 Sep50.00OTM0.002.150.900.00198.3% 0.02000.141-0.1460.011
put 1 JanITM12.8016.700.000.00278.5% +80.2000-0.859-0.1400.011
call 24 Sep55.00OTM0.002.150.550.00233.0% 0.02000.126-0.1580.011
put 1 JanITM17.8021.900.000.00331.1% +98.2000-0.874-0.1520.011

Latest SEC filings

30 of 653
AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings

10-Q filed 2026-11-09, period ended 2026-09-30. 10-K filed 2026-05-20, period ended 2026-03-31. IMVT on EDGAR

page 1 of 22Next →
FiledFormDescriptionPeriodDocument
2026-11-12144no categoryno report period0001950047-26-010982 index
2026-11-124Insider equity awards, transactions, and ownership (Section 16 Reports)2026-11-11 · transaction0001764013-26-000126 index
2026-11-09S-3ASRRegistration statements and prospectusesno report period0001764013-26-000124 index
2026-11-0910-QAll annual, quarterly, and current reports2026-09-300001764013-26-000122 index
2026-11-098-KAll annual, quarterly, and current reports2026-11-090001764013-26-000121 index
2026-10-304Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-28 · transaction0001764013-26-000117 index
2026-10-234Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-21 · transaction0001764013-26-000114 index
2026-10-094Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-07 · transaction0001779707-26-000009 index
2026-10-094Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-07 · transaction0001764013-26-000112 index
2026-10-094Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-07 · transaction0001702969-26-000012 index
2026-10-054Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-01 · transaction0001764013-26-000110 index
2026-09-254Insider equity awards, transactions, and ownership (Section 16 Reports)2026-09-23 · transaction0001764013-26-000108 index
2026-09-038-KAll annual, quarterly, and current reports2026-09-020001764013-26-000106 index
2026-08-284Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-28 · transaction0001764013-26-000103 index
2026-08-214Insider equity awards, transactions, and ownership (Section 16 Reports)2026-08-20 · transaction0001973838-26-000007 index
2026-08-14SCHEDULE 13G/ABeneficial ownership reportsno report period0001172661-26-003481 index
2026-08-0610-QAll annual, quarterly, and current reports2026-06-300001764013-26-000101 index
2026-08-068-KAll annual, quarterly, and current reports2026-08-060001764013-26-000100 index
2026-07-244Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-23 · transaction0001702969-26-000010 index
2026-07-244Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-24 · transaction0001643071-26-000007 index
2026-07-244Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-23 · transaction0001618670-26-000004 index
2026-07-22ARSProxy materials2026-03-310001764013-26-000094 index
2026-07-22DEFA14AProxy materialsno report period0001764013-26-000093 index
2026-07-22DEF 14AProxy materials2026-09-020001764013-26-000092 index
2026-07-104Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-08 · transaction0001764013-26-000083 index
2026-07-104Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-08 · transaction0001764013-26-000082 index
2026-07-104Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-08 · transaction0001764013-26-000081 index
2026-07-064Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-01 · transaction0001764013-26-000077 index
2026-06-26144no categoryno report period0001950047-26-006543 index
2026-06-26144no categoryno report period0001950047-26-006532 index

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100108.00K1
2026-1000619.47K6
2026-0900103.48K1
2026-0800199.86K2
2026-0700818.39K7
2026-06003.48M7
2026-05007.80M4
2026-04001.78M6
2026-030071.84K1
2026-020090.18K1
2026-010083.38K2
2025-12350.00M11.16M3
2025-1100298.24K1

Institutional holders

Manager% owned
FMR LLC7.60%
Deep Track Capital, LP4.55%
BlackRock, Inc.3.50%
FARALLON CAPITAL MANAGEMENT, L.L.C.2.83%
BAKER BROS. ADVISORS LP2.65%
Two Seas Capital LP2.23%
MORGAN STANLEY2.21%
TCG Crossover Management, LLC2.17%
STATE STREET CORP2.03%
VANGUARD PORTFOLIO MANAGEMENT LLC1.90%

Funds

Fund% owned
Fidelity Growth Company Fund2.47%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.27%
State Street(R) SPDR(R) S&P(R) Biotech ETF1.25%
iShares Russell 2000 ETF1.07%
VANGUARD SMALL-CAP INDEX FUND0.92%
Fidelity Growth Company K6 Fund0.68%
Fidelity Series Growth Company Fund0.53%
VANGUARD SMALL-CAP GROWTH INDEX FUND0.53%
T. Rowe Price Small-Cap Stock Fund, Inc.0.48%
PGIM Jennison Small Company Fund0.48%

OakChart. IMVT. Cached 15 minutes. Terms